Oxaliplatin-induced pancreatitis: A case series

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5113-5116

  Saadati, Hamid ^a   Butt, Waseem ^b   Saif, Muhammad Wasif ^c,d  

^a WRIGHT STATE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c College of Physicians and Surgeons ^*  (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Carcinoma; Oxaliplatin; Pancreatitis

Indexed keywords

AMYLASE; BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLON CANCER; DRUG DOSE REDUCTION; DRUG EXPOSURE; DRUG WITHDRAWAL; FEMALE; GALLBLADDER CARCINOMA; HUMAN; MALE; METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ACUTE DISEASE; AGED; ANTINEOPLASTIC AGENTS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PANCREATITIS;

EID: 78751471040     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ibrahim A, Hirschfeld S, Cohen MH, Griebel DJ, Williams GA and Pazdur R: FDA drug approval summaries: oxaliplatin. Oncologist 9: 8-12, 2004. (Pubitemid 38134009)
2. Cunningham D, Starling N, Rao S, Cao Y, Liao C, Tan A, Liu L, Mo Z and Gao F: Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358: 36-46, 2008.
3. Zhao JG, Qiu F, Xiong JP, Zhang L, Xiang XJ, Yu F, Yan J, Zhan ZY and Feng M: A phase II study of modified FOLFOX as firstline chemotherapy in elderly patients with advanced gastric cancer. Anticancer Drugs 20: 281-286, 2009.
4. Wagner AD, Buechner-Steudel P, Moehler M, Schmalenberg H, Behrens R, Fahlke J, Wein A, Behl S, Kuss O, Kleber G and Fleig WE: Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase- II trials. Br J Cancer 101: 1846-1852, 2009.
5. Demols A, Peeters M, Polus M, Marechal R, Gay F, Monsaert E, Hendlisz A and Van Laethem JL: Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. Br J Cancer 94: 481-485, 2006. (Pubitemid 43289750)
6. Bunin N, Meyer WH, Christensen M and Pratt CB7 Pancreatitis following cisplatin: a case report. Cancer Treat Rep 69: 236-237, 1985. (Pubitemid 15170468)
7. Tarin F, Camps C, Berrocal A and Vicent JM: Acute pancreatitis caused by cisplatin and vindesine. Rev Esp Enferm Dig 85: 224-225,1994.
8. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F and Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938-2947, 2000.
9. Kuebler JP, Wieand HS, O'Connell MJ, Smith RE, Colangelo LH, Yothers G, Petrelli NJ, Findlay MP, Seay TE, Atkins JN, Zapas JL, Goodwin JW, Fehrenbacher L, Ramanathan RK, Conley BA, Flynn PJ, Soori G, Colman LK, Levine EA, Lanier KS and Wolmark N: Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 25: 2198-2204, 2007.
10. André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F and de Gramont A: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27: 3109-3116, 2009.
11. Cao Y, Liao C, Tan A, Liu L, Mo Z and Gao F: Capecitabine plus oxaliplatin vs. fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner - meta-analysis of six randomized trials. Colorectal Dis 12: 16-23, 2010.
12. André T, Reyes-Vidal JM, Fartoux L, Ross P, Leslie M, Rosmorduc O, Clemens MR, Louvet C, Perez N, Mehmud F and Scheithauer W: Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study. Br J Cancer 99: 862-867, 2008.